文献速递肾小球疾病

B细胞疗法在狼疮性肾炎中的应用概述

B-cell therapy in lupus nephritis: an overview.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

本文综述B细胞疗法在狼疮性肾炎中的现有经验。B细胞、浆母细胞和浆细胞是自身抗体来源,是狼疮性肾炎的潜在治疗靶点。然而随机临床试验结果未达预期,而无对照队列和观察性研究显示B细胞拮抗剂更有前景。文章分析可能限制其成功的因素,并提出基于B细胞管理的策略。

要点

  • B细胞疗法在狼疮性肾炎随机临床试验中未达预期。
  • 无对照队列和观察性研究显示B细胞拮抗剂更有前景。
  • 需基于整体B细胞经验提出以B细胞为中心的管理策略。

核心结论

  • B细胞疗法在狼疮性肾炎随机临床试验中未达预期,但观察性研究显示希望。

研究设计与样本

  • 本文为综述,回顾B细胞疗法在狼疮性肾炎中的现有经验。

主要发现

  • B细胞、浆母细胞和浆细胞作为自身抗体来源,在狼疮性肾炎发展中起主要作用。
  • 随机临床试验未达预期,而无对照队列和观察性研究更有前景。

临床怎么用

  • 基于B细胞经验,可考虑以B细胞为中心的方法管理狼疮性肾炎。

局限性

  • 随机临床试验结果未达预期,可能限制B细胞疗法的成功。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic lupus erythematosus (SLE) is an autoimmune multisystem disease that commonly affects the kidneys. It is characterized by persistent autoantibody production that targets a multitude of self-antigens. B-cells, plasmablasts and plasma cells, as the source of these autoantibodies, play a major role in the development of lupus nephritis (LN), and are therefore promising therapeutic targets. To date, however, randomized clinical trials of B-cell therapies in LN have not lived up to expectations, whereas uncontrolled cohort and observational studies of B-cell antagonists have been more promising. In this article, we will review the current experience with B-cell therapy in LN and highlight the pitfalls that may have limited their success. We will conclude by suggesting B-cell-centric approaches to the management of LN based on what has been learned from the overall B-cell experience in SLE.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Almaani S, Rovin BH. B-cell therapy in lupus nephritis: an overview. Nephrol Dial Transplant. 2019. PMID: 30165690. doi:10.1093/ndt/gfy267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。